Skip to main content
Antimicrobial Agents and Chemotherapy logoLink to Antimicrobial Agents and Chemotherapy
. 1991 Jun;35(6):1035–1039. doi: 10.1128/aac.35.6.1035

Isoniazid inhibition of mycolic acid synthesis by cell extracts of sensitive and resistant strains of Mycobacterium aurum.

A Quémard 1, C Lacave 1, G Lanéelle 1
PMCID: PMC284282  PMID: 1656850

Abstract

Isonicotinic acid hydrazide (isoniazid; INH) inhibition of mycolic acid synthesis was studied by using cell extracts from both INH-sensitive and -resistant strains of Mycobacterium aurum. The cell extract of the INH-sensitive strain was inhibited by INH, while the preparation from the INH-resistant strain was not. This showed that the INH resistance of mycolic acid synthesis was not due to a difference in drug uptake or the level of peroxidase activity (similar in both extracts). As INH did not induce accumulation of any labeled intermediates, it is postulated that the drug acts either on production of labeled chain elongation precursors of mycolic acids or an early step of this elongation. The level of inhibition was not changed by addition of NAD or nicotinamide; thus, INH does not act on mycolic acid synthesis as an NAD antimetabolite. Benzoic or acetic acid hydrazides and known or postulated metabolites of INH (i.e., the corresponding acid, aldehyde, or alcohol) were not inhibitors of cell-free mycolic acid synthesis; the complete structure of INH was required, as already known for inhibition of mycobacterial culture growth. Extracts prepared from INH-treated cells showed reduced mycolic acid synthesis, and the inhibition level was not modified by either extensive dialysis or pyridoxal phosphate. This latter molecule efficiently antagonized INH action by reacting rapidly with INH, as shown by differential spectroscopy. Moreover, pyridoxal phosphate did not release inhibition of INH-treated extracts. It is proposed that INH may covalently react with an essential component of the mycolic acid synthesis system.

Full text

PDF
1035

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BOONE I. U., STRANG V. G., ROGERS B. S. Effect of pyridoxal on uptake of C14-activity from labeled isoniazid by Mycobacterium tuberculosis. Am Rev Tuberc. 1957 Oct;76(4):568–578. doi: 10.1164/artpd.1957.76.4.568. [DOI] [PubMed] [Google Scholar]
  2. Begg W. H., Jenne J. W. Capacity of tubercle bacilli for isoniazid accumulation. Am Rev Respir Dis. 1970 Jul;102(1):94–96. doi: 10.1164/arrd.1970.102.1.94. [DOI] [PubMed] [Google Scholar]
  3. Davidson L. A., Takayama K. Isoniazid inhibition of the synthesis of monounsaturated long-chain fatty acids in Mycobacterium tuberculosis H37Ra. Antimicrob Agents Chemother. 1979 Jul;16(1):104–105. doi: 10.1128/aac.16.1.104. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Devi B. G., Shaila M. S., Ramakrishnan T., Gopinathan K. P. The purification and properties of peroxidase in Mycobacterium tuberculosis H37Rv and its possible role in the mechanism of action of isonicotinic acid hydrazide. Biochem J. 1975 Jul;149(1):187–197. doi: 10.1042/bj1490187. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Lacave C., Laneelle M. A., Daffe M., Montrozier H., Laneelle G. Mycolic acid metabolic filiation and location in Mycobacterium aurum and Mycobacterium phlei. Eur J Biochem. 1989 May 1;181(2):459–466. doi: 10.1111/j.1432-1033.1989.tb14747.x. [DOI] [PubMed] [Google Scholar]
  6. Lacave C., Lanéelle M. A., Lanéelle G. Mycolic acid synthesis by Mycobacterium aurum cell-free extracts. Biochim Biophys Acta. 1990 Feb 23;1042(3):315–323. doi: 10.1016/0005-2760(90)90159-u. [DOI] [PubMed] [Google Scholar]
  7. Lacave C., Quémard A., Lanéelle G. Cell-free synthesis of mycolic acids in Mycobacterium aurum: radioactivity distribution in newly synthesized acids and presence of cell wall in the system. Biochim Biophys Acta. 1990 Jun 28;1045(1):58–68. doi: 10.1016/0005-2760(90)90203-a. [DOI] [PubMed] [Google Scholar]
  8. POPE H. The neutralization of isoniazid activity in Mycobacterium tuberculosis by certain metabolites. Am Rev Tuberc. 1956 May;73(5):735–747. doi: 10.1164/artpd.1956.73.5.735. [DOI] [PubMed] [Google Scholar]
  9. Takayama K., Wang L., David H. L. Effect of isoniazid on the in vivo mycolic acid synthesis, cell growth, and viability of Mycobacterium tuberculosis. Antimicrob Agents Chemother. 1972 Jul;2(1):29–35. doi: 10.1128/aac.2.1.29. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Walker R. W., Prome J. C., Lacave C. S. Biosynthesis of mycolic acids. Formation of a C32 beta-keto ester from palmitic acid in a cell-free system of Corynebacterium diphtheriae. Biochim Biophys Acta. 1973 Oct 17;326(1):52–62. doi: 10.1016/0005-2760(73)90027-1. [DOI] [PubMed] [Google Scholar]
  11. Winder F. G., Collins P. B. Inhibition by isoniazid of synthesis of mycolic acids in Mycobacterium tuberculosis. J Gen Microbiol. 1970 Sep;63(1):41–48. doi: 10.1099/00221287-63-1-41. [DOI] [PubMed] [Google Scholar]

Articles from Antimicrobial Agents and Chemotherapy are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES